Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

The team analyzed the effect of sampling frequency on the prediction error of IRs by using reduced sampling across different sewer sheds of varying sizes and features.

28 Feb 2022

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

Researchers generated a panel of bnAbs against SARS-CoV, SARS-CoV-2, and its variant VOCs, including Omicron from sequentially immunized mice.

28 Feb 2022

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Researchers emphasized the need to take on a holistic and unbiased approach to develop a universal vaccine for coronaviruses, including SARS-CoV-2, which is a biomedical priority during the ongoing COVID-19 pandemic.

28 Feb 2022

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Researchers evaluated the pathogenicity and replication potential of SARS-CoV-2 VOC Omicron lineage, BA.2 in immunocompetent mice and hamsters.

28 Feb 2022

Studying coagulopathy in COVID-19

A new study published in the journal Diagnostics provided an overview of ROTEM with a particular focus on interpreting the symmetrical clot formation curve. Researchers also introduced new parameters that could aid in distinguishing between COVID-19 patients and outcomes.

28 Feb 2022

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

In a new study published in ACS Infectious Diseases journal, scientists biochemically and structurally evaluated the PLpro from a subgroup 2b bat coronavirus, BtSCoV-Rf1.2004, to identify unique structural features or enzymatic biases of the subgroup 2b.

28 Feb 2022

Vaccination reduces risk of long-COVID

A new study posted on the medRxiv* preprint server investigated the difference between the likelihood of symptoms, 12 weeks after SARS-CoV-2 infection, among individuals who received two COVID-19 vaccination doses and unvaccinated individuals.

27 Feb 2022

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

In a recent research report from the United States, currently available on bioRxiv* preprint server, scientists have shown that bacterial taxonomic and functional profiles can discriminate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) status even without directly detecting viral transcripts – opening the door for entirely novel approaches in wastewater-based epidemiology.

27 Feb 2022

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

A team of scientists from Germany has recently conducted a serological screening on wild animals to assess seroprevalence against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other pathogenic viruses related to domestic ruminants.

27 Feb 2022

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

A new study estimates vaccine effectiveness against SARS-CoV-2 Omicron variant in indoor entertainment settings in Australia.

27 Feb 2022

Will Omicron BA.2 become the next dominant variant?

A new study presents a comprehensive analysis of the potential of both Omicron BA.2 and BA.3 to become the next dominant circulating SARS-CoV-2 strain.

27 Feb 2022

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

A new study discusses the emergence of new variants of SARS-CoV-2 that can escape antibody-mediated neutralization, as opposed to other Sarbecoviruses.

27 Feb 2022

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

A new study discusses changes in the microbiota of various parts of the body with SARS-CoV-2 infection.

27 Feb 2022

The epidemiology of COVID-19 in Africa

A new study uses the Africa CDC generic protocol for obtaining COVID-19 seroprevalence data to understand the spread and epidemiology of SARS-CoV-2.

27 Feb 2022

A promising new vaccine for SARS-CoV-2 and influenza

Researchers create a vaccine candidate that could protect against both SARS-CoV-2 and IAVs.

27 Feb 2022

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Researchers proposed an approach that assesses community-based case studies to examine vaccine hesitancy and the response to COVID-19-related public health behaviors in South Africa.

25 Feb 2022

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

The study findings show that the Omicron-dominant fourth wave of COVID-19 reversed the rising SARS-CoV-2 cases and hospitalization trend seen in the previous three waves in South Africa.

25 Feb 2022

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Researchers demonstrated that irrespective of the type of ACT, SARS-CoV-2 infection rates in patients receiving ACT remained comparable to the general population.

25 Feb 2022

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Researchers conducted a comprehensive and systematic analysis of functional SARS-CoV-2 antibody profiles in a controlled randomized trial of severe COVID-19 hospitalized individuals treated with COVID-19 CCP.

25 Feb 2022

Study suggests history of childhood traumas may increase the risk of long COVID

In a new study, researchers found childhood trauma to be a risk factor for post-coronavirus disease.

25 Feb 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Distributed lag models to estimate incident rates using concentrations of SARS-CoV-2 RNA from wastewater solids

Triple antibody cocktail is a promising candidate for immunotherapy against SARS-CoV-2 variants of concern

The need for a holistic and unbiased approach to develop a more universal vaccine for coronaviruses

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Studying coagulopathy in COVID-19

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Vaccination reduces risk of long-COVID

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

The epidemiology of COVID-19 in Africa

A promising new vaccine for SARS-CoV-2 and influenza

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Study suggests history of childhood traumas may increase the risk of long COVID

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Edoardo Fabini

Newsletters you may be interested in